Application 212399
- Type
- ANDA
- Sponsor
- ACCORD HLTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 002 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 003 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 004 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 005 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 006 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 007 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 008 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 009 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 010 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 011 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 012 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212399-001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-002 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-003 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-004 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-005 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-006 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-007 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-008 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-009 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-010 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-011 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | |
| A212399-012 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212399-001 | AB1 |
| A212399-001 | AB2 |
| A212399-001 | AB3 |
| A212399-001 | AB4 |
| A212399-002 | AB1 |
| A212399-002 | AB2 |
| A212399-002 | AB3 |
| A212399-002 | AB4 |
| A212399-003 | AB1 |
| A212399-003 | AB2 |
| A212399-003 | AB3 |
| A212399-003 | AB4 |
| A212399-004 | AB1 |
| A212399-004 | AB2 |
| A212399-004 | AB3 |
| A212399-004 | AB4 |
| A212399-005 | AB1 |
| A212399-005 | AB2 |
| A212399-005 | AB3 |
| A212399-005 | AB4 |
| A212399-006 | AB1 |
| A212399-006 | AB2 |
| A212399-006 | AB3 |
| A212399-006 | AB4 |
| A212399-007 | AB1 |
| A212399-007 | AB2 |
| A212399-007 | AB3 |
| A212399-007 | AB4 |
| A212399-008 | AB1 |
| A212399-008 | AB2 |
| A212399-008 | AB3 |
| A212399-008 | AB4 |
| A212399-009 | AB1 |
| A212399-009 | AB2 |
| A212399-009 | AB3 |
| A212399-009 | AB4 |
| A212399-010 | AB1 |
| A212399-010 | AB2 |
| A212399-010 | AB3 |
| A212399-010 | AB4 |
| A212399-011 | AB1 |
| A212399-011 | AB2 |
| A212399-011 | AB3 |
| A212399-011 | AB4 |
| A212399-012 | AB1 |
| A212399-012 | AB2 |
| A212399-012 | AB3 |
| A212399-012 | AB4 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A212399-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212399-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212399-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212399-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212399-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212399-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212399-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212399-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212399-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212399-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212399-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212399-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A212399-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212399-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212399-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212399-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212399-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212399-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212399-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212399-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212399-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212399-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212399-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212399-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212399-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212399-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2020-10-19 | 31067a03dcf5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A212399-001 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-001 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-001 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-001 | AB4 | 4 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-002 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-002 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-002 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-002 | AB4 | 4 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-003 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-003 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-003 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-003 | AB4 | 4 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-004 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-004 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-004 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-004 | AB4 | 4 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-005 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-005 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-005 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-005 | AB4 | 4 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-006 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-006 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-006 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-006 | AB4 | 4 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-007 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-007 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-007 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-007 | AB4 | 4 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-008 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-008 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-008 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-008 | AB4 | 4 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-009 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-009 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-009 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-009 | AB4 | 4 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-010 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-010 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-010 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212399-010 | AB4 | 4 | 84e616aacf4f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | a0fa8fa5-d3bd-4e52-9ec5-5fb84702826d | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 50090-6100 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 70853a82-ba3b-4663-9f78-6791ca72ba9f | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 7c8a6441-3c12-46ae-bb3b-a320d80045b6 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 008de8fd-150f-4022-8ccb-c8bfa94875c7 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 67f46137-afc4-471b-a6c7-9c2aef92da5d | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | PD-Rx Pharmaceuticals, Inc. | 70a9bb5c-2259-405e-8d89-cc1db8c70743 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | PD-Rx Pharmaceuticals, Inc. | 6f4998ac-0714-4f5d-8944-9e6902b9f0a6 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | fa7dd488-de7e-4f9e-87db-18391b723aad | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 4520fae0-acce-47a0-af9e-f4f16ea6b268 | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 50090-6101 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 2ce47caf-6ece-429c-b5d7-c47ba6952800 | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | ASCLEMED USA INC. | 42a26f8a-dc67-42e4-abb0-d2602afb1b7d | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | b717aff6-f754-458d-be87-d12d87c5da00 | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 50090-6087 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 62de26a8-d6fc-463f-abe6-4656228c3142 | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 36af0286-e447-4098-b3f2-772debd58667 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 50090-6103 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | e8142948-2bde-4f4b-931e-da43e91f2d59 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | d29bc0fd-5587-4a70-a505-f5aee1f115a6 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | d5b11dac-1acd-4aa2-b837-e3b90d4f6922 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db998119-a293-3568-e053-2995a90ac47a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | da570872-94a1-4852-e053-2995a90aacb6 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | da827567-810b-624d-e053-2a95a90a9bde | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 212399 ANDA212399 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 16729-447 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-447 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-447 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-447 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-448 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-448 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-448 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-448 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-448 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-448 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-448 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-449 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-449 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-449 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-449 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-449 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-449 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-449 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-450 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-450 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-450 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-450 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-450 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-450 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-450 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-451 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-451 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-451 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-451 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-451 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-452 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-452 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-452 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-452 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-452 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-452 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-452 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-453 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-453 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-453 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-453 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-453 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-453 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-454 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-454 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-454 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-454 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-454 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-454 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-454 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-455 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-455 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-455 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-455 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-455 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-455 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-455 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-456 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-456 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-456 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-456 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-456 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-456 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-457 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-457 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-457 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-457 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-457 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-457 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-458 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-458 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-458 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 16729-458 | Levothyroxine sodium | Levothyroxine Sodium | Accord Healthcare Inc. | ANDA | Current |
| 50090-6087 | Levothyroxine sodium | Levothyroxine Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-6089 | Levothyroxine sodium | Levothyroxine Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-6090 | Levothyroxine sodium | Levothyroxine Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-6100 | Levothyroxine sodium | Levothyroxine Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-6101 | Levothyroxine sodium | Levothyroxine Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-6103 | Levothyroxine sodium | Levothyroxine Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-6104 | Levothyroxine sodium | Levothyroxine Sodium | A-S Medication Solutions | ANDA | Current |